There have been numerous investigations on the effects of Cd on various organs. In the case of chronic Cd toxicity, renal dysfunction is one of the most sensitive indicators of adverse effects (Suzuki, 1980) . Moreover, damage to the kidney has been reported to be casually related to anemia, a very common manifestation in Cd intoxication, through the reduced production of erythropoietin in the kidney (Horiguchi et al, 1996) . Besides the kidney, chronic Cd administration affects lym-phatic and hematopoietic organs such as bone marrow, spleen, and thymus (Ficek, 1994; Kajikawa et al, 1981; Katsuta et al., 1993) . In itai-itai disease of Japan, the characteristic clinical manifestations of this disease include renal proximal tubular dysfunction and osteomalacia with pain, and aged females seem to be the most vulnerable targets of Cd toxicity (Kajikawa et al., 1974) . In general, aging may affect the sensitivity to toxic chemicals through changes in immunological, hematological, neurological, or endocrinological functions. Thus, in this study, we compared the effects of Cd on the kidney, spleen, thymus, and bone marrow in 2-, 4-, and 8-month-old male Wistar rats after repeated sc injections for 4 weeks. Cd contents and induced levels of metallothionein (MT) in the liver, kidney, and spleen were also compared.
MATERIALS AND METHODS
Animals. Male Wistar rats (Japan CLEA, Osaka, Japan) were obtained at 4 weeks of age for use at 2, 4, and 8 months of age. They were maintained on a 12-h light-dark cycle and were given free access to food (MF, Oriental Yeast Co., Tokyo, Japan) and water.
Cd administration. Rats of each age were assigned to four groups of four animals each. The rats were injected subcutaneously with saline (2.5 ml/kg) or CdCl 2 dissolved in saline (0.5, 1, or 2 mg Cd/kg) (Wako Pure Chemicals, Osaka, Japan) three times per week (on every Monday, Wednesday, and Friday) for 4 weeks. Injections were started at 2, 4, or 8 months of age. Body weight was recorded just before each injection. Food was withdrawn after the last Cd administration.
Twenty-four hours after the last administration of CdCI 2 or its vehicle, rats were anesthetized with diethyl ether, and blood was collected from the abdominal aorta. Heparin was used as anticoagulant for counting blood cells. Then ice-cold saline was perfused into the portal vein before removal of organs. Liver, kidney, spleen, and thymus were removed and weighed. Portions of the liver, kidney, and spleen were kept frozen for the determination of Cd and MT contents.
Blood assays. Red and white blood cells were counted with a Coulter Counter (Coulter Electronics, Inc., Florida). Hemoglobin (Hb) was determined by a colorimetric method. Serum alanine aminotransferase (ALT) activity and blood urea nitrogen (BUN) were determined using commercially available kits: Iatrozyme TA-LQ (Iatron, Tokyo, Japan) and the urea nitrogen test (Wako, Osaka Japan), respectively. ALT activity is expressed as Karmen units (KU)/ml of serum.
Cd and MT analysis. Samples of each tissue (liver, kidney, and spleen) were digested in concentrated nitric acid and hydrogen peroxide. Cd concen- Relative liver, kidney, and spleen weights and red blood cell counts, hemoglobin concentrations, and white blood cell counts after repeated sc administration of Cd to 2-, 4-, and 8-month-old rats (2M, 4M, and 8M). Four rats in each group were treated sc with 0, 0.5, 1, or 2 mg/kg of Cd for 4 weeks (three times per week). Each value is expressed as the percentage of the corresponding control value. (a,b) Significantly different from corresponding control value (0 mg of Cd/kg) of the same age at P < 0.05 and 0.01, respectively, by the Dunnett test. (*•**) Dose-dependent Cd effect was significantly different between two age groups using two-way ANOVA followed by the Scheffe test, P < 0.05 and 0.01, respectively. Means ± SD values of control group for 2-, 4-, and 8-month-old rats were 11.0 ± 0.6, 12.0 ± 0.6, and 12.9 ± 1.4 g for liver; 2.32 ±0.10, 2.58 ±0.12, and 2.62 ± 0.23 g for kidney; and 0.76 ± 0.06, 0.84 ± 0.03, and 0.89 ± 0.10 g for spleen and 6.49 ± 0.51, 6.97 ± 0.34, and 7.41 ± 0.70 X 10 6 /mm 3 for RBC counts; 13.7 ± 0.5, 14.8 ± 0.4, and 15.7 ± 0.8 g/dl for Hb concentrations; and 15.6 ± 4.0, 13.9 ± 3.3, and 18.0 ± 7.0 X 10 3 /mm 3 for WBC counts.
tration in the digest was measured by inductive coupled plasma spectrometric analysis. Other parts of the tissues were homogenized with 4 vol of 0.25 M sucrose and centrifuged at 18,000g for 15 min at 4°C for the determination of cytosolic MT content. MT concentrations in the sucrose supernatants were determined using the Cd hemoglobin assay as described by Onosaka and Cherian (1982) . MT concentration in each tissue was calculated in micrograms of MT per gram of tissue, assuming a molecular weight of 6600 and 7 mol Cd atom bound/mol MT (Winge and Miklossy, 1982) .
Histological examination. Portions of the liver, kidney, and spleen and whole thymus and femoral bone were fixed in 10% neutral buffered Formalin and embedded in paraffin; 5-jim sections were stained with hematoxylin and eosin (H&E) for histological examination. The tissue slides were scored by an evaluator blind to the treatment group.
Statistics. Results are expressed as the means ± SD. Differences of the mean values for treated vs the corresponding control group of the same age were compared using the Dunnett test. The effect of age on dose-dependent Cd effect was examined using two-way ANOVA. Analysis of the age effect with organ weights and blood parameters was performed after transformation of each value to the percentage of mean value of the corresponding control group of the same age. Age effect between any two ages was examined by the Scheffe test following two-way ANOVA.
RESULTS
Effects on body weights. All rats in each group survived throughout experiments. Figure 1 shows body weight gain of rats during the experimental period. Dose-related retardations in body weight gain were more prominent in 4-and 8-month-old rats than in 2-month-old rats. The age-dependent difference in body weight gain was most evident at a dose of 1 mg Cd/kg. Effects on organ weights and hematological and serum biochemical parameters. The relative organ weights of the liver, kidney, and spleen to body weights were increased by Cd in a dose-dependent manner in all age groups (Fig. 2) . Splenomegaly was one of the most sensitive endpoints of Cd effects in this study. In the 8-month-old group even the lowest does of Cd (0.5 mg/kg) increased relative spleen weight significantly. The age effect on Cd-induced increases in the relative weights of the liver and spleen were significant by two-way ANOVA (Fig. 2) . The absolute and relative weights of the thymus were not influenced significantly in any age .group, even at the highest dose of Cd (2.0 mg/kg). Hematologic tests showed that red blood cell counts and hemoglobin concentrations decreased in the same dose-related manner in 4-and 8-month-old groups (Fig. 2) . These parameters were not affected in the 2-month-old rats by the doses of Cd used in this study. On the other hand, white blood cell counts were significantly increased by Cd administration in all age groups (Fig. 2) . As shown in Table 1 , the increases in white blood cell counts were accountable by the increased percentage of neutrophils in the differential white blood cell. The age effects on these three hematologic parameters were statistically significant. Serum biochemical test showed no increases in ALT activities in any age group. With respect to the serum BUN level, significant increases were observed at 2 mg Cd/kg in all age groups (Table 2) .
Cd and MT concentrations of the liver, kidney, and spleen.
Cd concentrations of the liver, kidney, and spleen in each age group after 4 weeks of injections are shown in Fig. 3 . Although the scales for the concentrations are different for the three organs, each organ accumulated Cd in a dose-dependent manner in the dose range employed in this study. Age effects on Cd accumulation were statistically significant for all three organs, and 8-month-old rats had slightly but significantly higher concentrations of Cd than the younger age groups. The patterns of the increases in MT concentrations in three organs in each age group resembled the patterns of Cd concentrations of corresponding organs exactly (Fig. 3) . Accordingly, when compared as the ratio of MT to Cd in the organs, these values were not significantly different among three age groups. 13.1 ± 1.7 12.7 ± 1.7 10.5 ± 1.0 2 12.4 ± 1.6** 18.4 ± 6.3 17.8 ± 7.7 19.8 ± 3.3* 22.6 ± 6.8* 17.6 ± 2.4** Note. Rats at 2. 4. and 8 months of age (2M. 4M. and 8M) were subcutaneously treated with 0. 0.5. 1. or 2 mg/kg of Cd for 4 weeks (three times per week). Values are means ± SD for four rats. ***: Significantly different from control at P < 0.05 and 0.01. respectively, by the Dunnett test. Cd and cytosolic MT concentrations of the liver, kidney, and spleen after repeated sc administration of Cd to 2-, 4-, and 8-month-old rats (2M, 4M, and 8M). Four rats in each group were treated sc with 0, 0.5, 1, or 2 mg/kg of Cd for 4 weeks (three times per week). Each value represents mean ± SD. (*•**) Dose-dependent Cd effect was significantly different between two age groups using two-way ANOVA followed by the SchefK test, P < 0.05 and 0.01, respectively.
Histopathology. Scores of microscopic findings in kidney, spleen, thymus, and bone marrow at the end of Cd injections are shown in Table 3 . Degenerative changes of renal tubules appeared at a dose of 2.0 mg Cd/kg in 2-and 4-month-old rats and at 1.0 mg Cd/kg in 8-month-old rats (Fig. 4a) . Increased fibrous tissue proliferation in the thymus compared to control group became to be marked at lowest dose of Cd (0.5 mg/kg) in 4-and 8-month-old groups (Fig. 4b) . Microscopic findings in bone marrow were also a sensitive indicator of Cd effects. In control groups, the ratio of the area of hematopoietic cells to that of fat cells in bone marrow decreased according to aging. With Cd treatment, the ratio of the areas was hardly affected in 2-month-old rats but significantly increased in 4-and 8-monthold rats (Fig. 5) . Hyperplasia of lymph follicles in the spleen was seen at doses of more than 1.0 mg Cd/kg in 4-and 8-month-old rats (Fig. 6 ).
DISCUSSION
Most of the Cd-induced effects on the liver, kidney, spleen, thymus, and bone marrow and on some hematologic parameters observed in this study have been reported elsewhere (Suzuki, 1980; Kajikawa et al, 1981; Morgan et al, 1984; Godowicz, 1988; Ficek, 1994) . Our main purpose was to examine how aging influences Cd toxicity using male rats of three different age groups. Essentially all of the effects observed, such as decrease in body weight gain, increases in the liver and spleen weights, decreases in red blood cell counts, and increases in white blood cell counts, were worsened as a consequence of aging. Moreover, abnormal histological findings, including renal tubular degeneration, increase in hematopoietic cells in bone marrow, and fibrous tissue proliferation in the spleen, thymus, and bone marrow increased in frequency with increasing animal age.
The major exposure of people to Cd is through food intake. Ingested Cd is assumed to bind to mucosal metallothionein in the intestine; then the Cd-MT complex is released into the systemic circulation (Elsenhans et al, 1997) . Aging would modify various transport systems of the intestine (Teillet et al, 1995) . Tissue MT levels are also influenced by aging (Luce et al, 1993; Shaikh et al, 1993) . Accordingly, it is quite possible " Number of rats with lesions. Number examined was four for all groups. Blank spaces indicate that the tissue of all rats within the group were normal.
that intestinal absorption of Cd is influenced by aging. In this study, we used the subcutaneous route to avoid the involvement of age-related differences in intestinal Cd absorption. Chronic administration of Cd affects the kidney as its most sensitive target organ. There have been several reports about age-related differences in the nephrotoxicity of Cd. Braunlich and Otto (1984) reported that juvenile rats (5 and 10 days old) are resistant to Cd-induced nephrotoxicity because of the immaturity of renal tubular cells. With respect to adult animals, comparable to our study, Shibasaki et al. (1996) reported that the aged hamster (60 weeks) is more susceptible than younger ones (16 weeks) to renal damage produced by repeated sc injections of Cd, evidenced by both morphological and functional changes. In our study, renal tubular morphological changes were age-related, while a biochemical parameter of renal dysfunction (BUN level) was not. In the case of chronic iv injections of Cd in ovariectomized rats, BUN was a less sensitive indicator than urinary volume and enzymes, and the most sensitive endpoint was morphological change in renal tubules (Jiratsuka et al., 1996) . Although we did not conduct urinalysis, renal histological observation was apparently more a sensitive endpoint than BUN level and represented age effects of Cd well.
Anemia and increase in neutrophils were also age-related phenomena. Although blood cells are sensitive targets of Cd intoxication (Morgan et al., 1984; Hiratsuka et al., 1996) , less is known about the influence of aging on Cd toxicity on lymphatic and hematopoietic organs such as spleen, thymus, and bone marrow. In this study, histological change in thymus and bone marrow in older rats was the most sensitive endpoint of Cd toxicity. Ficek (1997) reported Cd accumulation and concomitant histological damages in thymus after repeated sc injections in mice. Apparently, the concentration of Cd in the target tissue is the most critical determinant of the degree of injury. Subcutaneously administered Cd accumulated mainly in the liver (Fig. 2) . Sudo et al. (1996) reported that administered Cd first accumulates in the liver as a MT-binding form. The Cd-MT complex is then released into plasma and brought to the kidney, where a small part of the Cd is released as the cellular membrane-binding form, which initiates renal injury. Sauer et al. (1997) reported that pretreatment of rats with all-frans-retinol reduced the testicular toxicity of Cd as a consequence of increased capacity of the liver to retain administered Cd through induction of hepatic MT. Accordingly, the ability of the liver to complex the Cd seems to play a very important role in the distribution of Cd in extrahepatic tissues. With respect to the effect of age on hepatic ability to retain Cd, Goering and Klaassen (1984) reported higher levels of hepatic MT related to higher accumulations of Cd in immature rats, resulting in less sensitivity to Cd-induced hepatotoxicity. On the other hand, Wormser and Nir (1988) reported that high mortality occurred in aged rats (24 months old) following three successive ip injections of Cd, in spite of a higher induction rate of hepatic MT in aged rats. In this case, it is assumed that MT lost its capacity to retain Cd in aged rats. In our study, 8-month-old rats accumulated the highest amount of Cd in the liver, with a concomitant increase in hepatic MT content. Thus, hepatic ability to accumulate Cd seemed not to be impaired in the older animals. Extrahepatic organs such as the kidney and spleen also accumulated higher levels of Cd with aging, accompanied by higher induction of MT in these organs. Although we did not directly determine the concentration of "free" Cd in the organs, the age-dependent differences in susceptibility of extrahepatic tissue to Cd by a factor of aging may not simply be explained by the differences of tissue distribution of Cd. A combination of changes in immunological, hematological, neurological, or endocrinological functions with aging might be related to this phenomenon.
Recently, cytokines have been reported to play a role in several aspects of Cd-induced toxicity. Kayama et al. (1995a,b) reported that tumor necrosis factor-a and interleukin-6 are released in the course of Cd toxicity from Kupffer cells in liver or glomerular mesangial cells in kidney. It is known that that property of some cytokines is influenced by aging. Another possible explanation of the age effect would be that rapid clearance of the fairly high doses of cadmium slows down in the older rats, resulting in an increase in toxicity by sustained higher blood cadmium concentrations. Further study is needed to clarify the underlying mechanisms responsible for age-dependent changes in Cd-induced toxicity.
